Related Experiment Video
Updated: Feb 22, 2026
06:16
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
13.5K
Proteasome activity is required for T lymphocyte aggregation after mitogen activation.
1Research Center, Notre-Dame Hospital, CHUM, University of Montreal, Montreal, Canada.
Journal of Cellular Biochemistry
|March 10, 2001
Summary
The proteasome regulates T lymphocyte aggregation by controlling adhesion molecule expression. Inhibiting proteasome activity with lactacystin reduces T cell clustering and cell-cell interactions.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The proteasome is crucial for T lymphocyte proliferation and activation.
- Its role in lymphocyte aggregation remains to be fully elucidated.
Purpose of the Study:
- To investigate the proteasome's function in T lymphocyte aggregation.
- To determine the effect of proteasome inhibition on cell-cell interactions.
Main Methods:
- T lymphocytes were stimulated with mitogens.
- Proteasome activity was inhibited using lactacystin (LAC).
- Expression of adhesion molecules ICAM-1 and LFA-1 was analyzed.
Main Results:
- Lactacystin treatment prevented T lymphocyte aggregation.
- ICAM-1 and LFA-1 expression on activated T cells decreased after LAC treatment.
- LAC inhibited ICAM-1 at the mRNA level and LFA-1 post-translationally.
Conclusions:
- The proteasome plays a significant role in T cell aggregation.
- Proteasome-mediated regulation of adhesion molecules is critical for T cell-cell interactions during activation.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
01:24B Cell Activation and Differentiation
17.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.2K
01:16TGF - β Signaling Pathway
10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
01:13The Proteasome
1.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.8K
02:18The Proteasome
10.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.3K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K